Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Helen Collins


DPhil Student


I completed my BA in Cells and Systems Biology at Oxford in 2018, majoring in Cardiovascular, Renal and Respiratory Physiology and minoring in Neuroscience. In am currently in my fourth year of the Wellcome Trust 1+3 DPhil in Neuroscience, working in the Sharp group, having completed rotation projects in this lab and in Emptage group.


I am in the third year of my DPhil, studying the behavioural and neurophysiological effects of SSRI discontinuation. Recent publications suggest that up to half of patients discontinuing an SSRI antidepressant will experience withdrawal symptoms, for example nausea, dizziness, anxiety and sleep disturbances. Despite much clinical and anecdotal evidence of SSRI discontinuation syndrome, there are vanishingly few preclinical studies of the condition.

I am currently working on optimising a mouse model of SSRI discontinuation, as well as identifying key behavioural tests that can be used to establish its presence. I am also using molecular techniques to investigate the underlying neurobiological changes occurring following discontinuation that may contribute to the symptoms.